Enhabit (NYSE:EHAB) CAO Sells 1,403 Shares

Enhabit, Inc. (NYSE:EHAB) CAO Collin Mcquiddy sold 1,403 shares of the stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $13.61, for a total transaction of $19,094.83. Following the completion of the transaction, the chief accounting officer owned 3,991 shares of the company’s stock, valued at approximately $54,317.51. This represents a 26.01% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Enhabit Price Performance

Shares of Enhabit stock traded up $0.02 during trading on Wednesday, hitting $13.62. 2,806,514 shares of the company’s stock traded hands, compared to its average volume of 2,568,830. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.63 and a quick ratio of 1.63. The firm’s fifty day moving average price is $11.39 and its 200 day moving average price is $9.49. Enhabit, Inc. has a twelve month low of $6.47 and a twelve month high of $13.68. The company has a market cap of $690.55 million, a PE ratio of -151.28 and a beta of 1.56.

Enhabit (NYSE:EHAB) last issued its earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.14. The business had revenue of $270.40 million during the quarter, compared to analysts’ expectations of $270.56 million. Enhabit had a positive return on equity of 4.71% and a negative net margin of 0.43%. Analysts forecast that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Institutional Trading of Enhabit

Several institutional investors and hedge funds have recently made changes to their positions in the business. Corient Private Wealth LLC boosted its position in shares of Enhabit by 49.2% in the 4th quarter. Corient Private Wealth LLC now owns 14,967 shares of the company’s stock worth $138,000 after purchasing an additional 4,933 shares during the last quarter. Empowered Funds LLC increased its holdings in shares of Enhabit by 11.1% in the fourth quarter. Empowered Funds LLC now owns 262,221 shares of the company’s stock worth $2,418,000 after acquiring an additional 26,287 shares in the last quarter. Polymer Capital Management US LLC acquired a new stake in shares of Enhabit during the fourth quarter worth about $169,000. Eversept Partners LP acquired a new stake in shares of Enhabit during the fourth quarter worth about $2,015,000. Finally, Abel Hall LLC bought a new position in shares of Enhabit during the 4th quarter valued at about $143,000.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on EHAB shares. Leerink Partners upped their target price on shares of Enhabit from $9.50 to $13.80 and gave the stock a “market perform” rating in a report on Monday, February 23rd. UBS Group restated a “neutral” rating and issued a $13.80 price target (up from $12.00) on shares of Enhabit in a research report on Tuesday, February 24th. Deutsche Bank Aktiengesellschaft raised shares of Enhabit to a “buy” rating in a research note on Tuesday, January 13th. Wolfe Research set a $12.00 target price on shares of Enhabit in a research note on Thursday, January 8th. Finally, Jefferies Financial Group downgraded Enhabit from a “buy” rating to a “hold” rating and boosted their target price for the stock from $12.50 to $13.80 in a report on Monday, February 23rd. Two equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $13.57.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.